Human papilloma virus screening
Diagnostic TestHuman papilloma virus self-collection (HPVSC) kits will be provided to screen HPV.
NCT Number: NCT07294066
The purpose of this study is to test the feasibility and acceptability of a multi-level, community-engaged intervention to increase access to cervical cancer screening using human papillomavirus (HPV) self-collection (HPVSC) outreach among women living in a high-risk rural county and to improve navigation for follow-up screening.
A one-group intervention evaluation design will be used to pilot test feasibility and acceptability and to assess the proportion of women who return HPVSC kits and test HPV-positive. At the community level, local community-based organizations (CBOs) will serve as HPVSC kit distribution sites. At the individual level, trained community health workers will work with CBOs to support women throughout the HPVSC process, including specimen collection, kit return, result notification, and follow-up clinic-based screening for women who test HPV-positive.
Trial opening soon.
Get Notified30 year–64 year
Female
Interventional
Not applicable
The RE-AIM framework will be applied to selected domains to assess feasibility using predefined parameters. Quantitative surveys will measure acceptability of intervention components among women and community partners, and qualitative interviews will explore their experiences with the intervention.
The RE-AIM framework is a comprehensive tool for evaluating public health and community-based interventions. It focuses on five key dimensions: Reach, which assesses the number, proportion, and representativeness of individuals who participate in a program; Effectiveness, which measures the impact of the intervention on important outcomes, including potential negative effects; Adoption, which examines the number and representativeness of settings or staff that implement the program; Implementation, which evaluates how well the intervention is delivered as intended, including consistency and costs; and Maintenance, which considers the sustainability of both the intervention and its effects over time at individual and organizational levels.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Woman participants
Inclusion criteria
Exclusion criteria
Community partners participants
Inclusion criteria
Exclusion criteria
Human papilloma virus self-collection (HPVSC) kits will be provided to screen HPV.
Time frame: Up to 6 months
Proportion of eligible unscreened women recruited, with a target enrollment of 100 participants from Lenoir County.
Time frame: Up to 6 months
Ratio of returned HPV self-collection kits to kits distributed, and rate of participant withdrawal or loss to follow-up.
Time frame: Up to 6 months
Rate of HPV-positive screening rate among woman started study will be reported.
Contact information is provided by the study sponsor or research team.
UNC Lineberger Comprehensive Cancer Center
Other
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina Aim 3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07624123
Blood-Borne Infections, Cervix Cancer
Harare, Zimbabwe
View Trial DetailsNCT07545746
Blood-Borne Infections, CIN
Kisumu, Kenya
View Trial DetailsNCT05521997
Advanced Cervical Carcinoma, Cancer of the Cervix
St Louis, Missouri, United States
View Trial DetailsNCT07245381
Cervix Cancer, Female Urogenital Diseases
View Trial Details